Both in Medical Labs
GRAIL vs Veracyte
Over the past year GRAL returned +78.0% and VCYT returned +45.4%; their daily moves had a correlation of 0.43.
GRAL +78.0% VCYT +45.4%Growth of $1, one year, split-adjusted
| Metric | GRAL | VCYT |
|---|---|---|
| Price | $143.66 | $52.52 |
| Market cap | $6.42B | $4.22B |
| Today | +3.03% | +4.43% |
| 1 month | +4.6% | +17.6% |
| 6 months | +128.9% | +27.5% |
| Year to date | +67.8% | +24.8% |
| 1 year | — | +44.1% |
| Revenue growth (YoY) | +25.7% | +15.5% |
| Gross margin | −28.1% | 72.2% |
| Net margin | −246.7% | 17.0% |
| P/E (TTM) | — | 36.9× |
| Price / sales | 38.8× | 7.5× |
| Net cash | $861.6M | $485.2M |
| Dividend yield | — | — |
| Volatility (60d) | 96.8% | 54.6% |
| Short % of float | 19.3% | 12.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).